Your latest cannabis business info from Europe

Your latest cannabis business info from Europe


Cannabidiol (CBD): a promising anti-cancer weapon

Cannabidiol (CBD): a promising anti-cancer weapon

Cancer is a complex and powerful enemy of the human body, and experts are constantly looking for new approaches to fight it. Inflammation is a critical factor in the genesis of cancer and is essential to its development. Cannabidiol (CBD) may be able to slow the growth of breast cancer tumours, according to a recent discovery by experts from Mexico. Let’s explore this remarkable development and what it means for the fight against cancer.

The CBD connection: from lab to mouse

In earlier research, scientists looked into how CBD affected MCF-7 cells, which are human breast cancer cells. These cells were exposed to the inflammatory cytokine IL-1, which caused these cells to develop a malignant phenotype and the ability to form tumours. It turned out that CBD has the amazing capacity to stop this transformation.

The true test, however, was still to come. The use of mice as an animal model allowed researchers to test if CBD might effectively treat cancer in a living organism. These mice received the cancerous 6D cells. The anticipations expected that they would grow tumours as a result. The outcomes were truly ground-breaking.

CBD’s impact: therapeutic and prophylactic

CBD was given to the mice in two separate ways by the researchers: therapeutically and preventatively. In the therapy plan, CBD was administered to the mice after the tumours had already developed. Surprisingly, compared to mice who weren’t given CBD, those who did demonstrated a considerable decrease in tumour size. This suggested that CBD might successfully stop tumour growth in its tracks.

In the preventative plan, mice received a CBD pre-treatment before receiving 6D cells. Surprisingly, the majority of these mice had little tumours, which the ongoing CBD treatment eliminated. This finding suggested that CBD might be useful in preventing the growth of tumours.

The science behind CBD’s success

Researchers examined the tumours histologically and molecularly to see why CBD was so successful. They discovered that CBD-treated cells showed evidence of the cell-death process known as apoptosis as well as a decrease in the expression of malignancy markers. This suggests that CBD may possibly induce cancer cells to self-destruct in addition to inhibiting the growth of tumours.

Because larger doses had been found to have negative effects in earlier studies, the researchers took care to provide CBD at the recommended amount of 3.14 mg/kg. They were able to conduct their research on CBD’s inhibitory effects on tumour development and survival with this dosage without harming the mice.

It’s interesting to note that the results suggested that early-stage tumour detection may increase CBD’s ability to prevent tumour growth. This suggests that CBD might be a useful tool for the early detection and treatment of cancer.

A glimpse into the future

In conclusion, this research moves us one step closer to realising CBD’s promise as a breast cancer treatment. Cancer patients have hope since, when used properly, CBD can prevent tumour growth without harming healthy tissue. Its capacity to control the expression of cancerous characteristics and encourage apoptosis in tumour cells is encouraging for the development of new cancer therapies. We highly encourage to look at detailed information in the publication.

These results offer some hope to those battling this terrible disease, even though there is still much to discover and investigate about anti-inflammantory CBD and cancer therapy. The war against cancer is still going on, and CBD could be a useful partner in the ongoing battle.


Environmental impact of disposable cannabis vapes

Renovation of Serbian houses with hemp wool as insulation

PGPR: Bacterias for sustainable cannabis cultivation


Germany: protection zones with the “Bubatzkarte”

Promising future of medical cannabis in Spain: €335 Million by 2030